首页> 外国专利> Composition for the treatment of hyperlipidaemia is a Derivative of oxintomodulina (Divisional Application 0177 - 2015).

Composition for the treatment of hyperlipidaemia is a Derivative of oxintomodulina (Divisional Application 0177 - 2015).

机译:用于治疗高脂血症的组合物是催产激素调节剂的衍生物(分部申请0177-2015)。

摘要

p a composition for preventing or treating hyperlipidemia, fatty liver or artenoesclerosis comprising a oxintomodulina derivative as active ingredient.The Derivative of oxintomodulina has a great capacity to activate the receptor G1 - P - 1 and Glucagon Receptor in comparison with the native oxintomodulina and has the effects of reducing the levelTheir Blood cholesterolLow Density cholesterol and triglycerides are elevated by High Fat diets and increase the levels of HDL cholesterol and ratio of cholesterolHigh and low density. Therefore, the oxintomodulina derivative can be effectively used for the treatment of hyperlipidemia and related diseases, / p
机译:>一种用于预防或治疗高脂血症,脂肪肝或动脉粥样硬化的组合物,其包含毒素调节蛋白衍生物作为活性成分。与天然的毒素调节蛋白相比,该毒素调节剂具有极大的激活受体G1-P-1和胰高血糖素受体的能力。降低胆固醇的作用他们的血液胆固醇低密度胆固醇和甘油三酸酯通过高脂饮食而升高,并增加HDL胆固醇的水平和胆固醇的比率高低密度。因此,催产激素调节素衍生物可以有效地用于治疗高脂血症和相关疾病。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号